Evidence map›Paper›PMID 42624904›Full record

ArticleCommunications chemistry2026

Continuous-flow photogeneration of nitrosobenzaldehydes enables indazolone formation.

Nicolas Leclercq, Diana V Silva-Brenes, Jean-Christophe M Monbaliu, Marcus Baumann

Abstract read
In one paragraph

Article in Communications chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nicolas LeclercqSchool of Chemistry, University College Dublin, Science Centre South, Belfield, Ireland.
Diana V Silva-BrenesCenter for Integrated Technology and Organic Synthesis (CiTOS), MolSys Research Unit, University of Liège, Liège, Belgium.ORCID http://orcid.org/0000-0002-7613-8888
Jean-Christophe M MonbaliuCenter for Integrated Technology and Organic Synthesis (CiTOS), MolSys Research Unit, University of Liège, Liège, Belgium. jc.monbaliu@uliege.be.ORCID http://orcid.org/0000-0001-6916-8846
Marcus BaumannSchool of Chemistry, University College Dublin, Science Centre South, Belfield, Ireland. marcus.baumann@ucd.ie.ORCID http://orcid.org/0000-0002-6996-5893

Funding

EC | Erasmus+ B LIEGE01Fonds De La Recherche Scientifique - FNRS (Belgian National Fund for Scientific Research) 2.5020.11a.
6 · The paper itself

Abstract

1,2-Dihydro-3H-indazol-3-ones (indazolones) are nitrogen-containing heterocycles with broad biological relevance, yet their synthesis often relies on harsh conditions or expensive metal catalysts. Herein, we report a metal-free continuous-flow photochemical protocol that enables rapid access to indazolone cores under mild and sustainable conditions. Direct irradiation of o-nitrobenzyl alcohols in ethanol at 365 nm generates o-nitrosobenzaldehydes in situ, which subsequently undergo condensation-cyclization with primary amines to afford indazolones. UV-visible spectroscopy combined with conceptual DFT analysis suggests that reaction efficiency is governed by wavelength-dependent substrate absorption: weak absorbers generate nitroso intermediates inefficiently, whereas strongly absorbing substrates undergo competitive photodegradation. By matching the irradiation wavelength to the absorption properties of individual substrates, the accessible chemical space can be extended beyond that obtained under fixed-wavelength conditions. Conceptual DFT further rationalizes substituent-dependent electronic effects, clarifying how photophysical and polar reactivity factors jointly control productive indazolone formation. The reaction scalability is assessed with commercial flow reactors.

Identifiers

PMID42624904
PMCPMC13493808

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.